LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $928,000 | +455.7% | 7,383 | +427.4% | 0.20% | +326.1% |
| Q2 2016 | $167,000 | +11.3% | 1,400 | 0.0% | 0.05% | +15.0% |
| Q1 2016 | $150,000 | -1.3% | 1,400 | 0.0% | 0.04% | -2.4% |
| Q4 2015 | $152,000 | -71.9% | 1,400 | -77.8% | 0.04% | -64.7% |
| Q3 2015 | $540,000 | +53900.0% | 6,300 | +31400.0% | 0.12% | – |
| Q2 2014 | $1,000 | -99.9% | 20 | -99.9% | 0.00% | -100.0% |
| Q1 2014 | $1,223,000 | +27.5% | 18,191 | -0.3% | 0.14% | +20.7% |
| Q4 2013 | $959,000 | +20.9% | 18,241 | -0.5% | 0.12% | +13.7% |
| Q3 2013 | $793,000 | +15.8% | 18,341 | 0.0% | 0.10% | +8.5% |
| Q2 2013 | $685,000 | – | 18,341 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |